ID   GLT10_HUMAN             Reviewed;         603 AA.
AC   Q86SR1; B3KXC9; Q6IN56; Q86VP8; Q8IXJ2; Q8TEJ2; Q96IV2; Q9H8E1;
AC   Q9Y4M4;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   10-MAY-2017, entry version 137.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 10;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 10;
DE            Short=GalNAc-T10;
DE            Short=pp-GaNTase 10;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 10;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10;
GN   Name=GALNT10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon cancer;
RX   PubMed=12417297; DOI=10.1016/S0014-5793(02)03399-9;
RA   Cheng L., Tachibana K., Zhang Y., Guo J.-M., Tachibana K.K.,
RA   Kameyama A., Wang H., Hiruma T., Iwasaki H., Togayachi A., Kudo T.,
RA   Narimatsu H.;
RT   "Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-
RT   T10.";
RL   FEBS Lett. 531:115-121(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bennett E.P.;
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 117-603 (ISOFORM 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-366 (ISOFORM 3).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 191-603 (ISOFORM 1).
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 40-603 IN COMPLEX WITH
RP   UDP-GALNAC AND GALNAC-SERINE, DISULFIDE BOND, MANGANESE-BINDING SITES,
RP   AND GLYCOSYLATION AT ASN-124; ASN-146 AND ASN-593.
RX   PubMed=16650853; DOI=10.1016/j.jmb.2006.03.061;
RA   Kubota T., Shiba T., Sugioka S., Furukawa S., Sawaki H., Kato R.,
RA   Wakatsuki S., Narimatsu H.;
RT   "Structural basis of carbohydrate transfer activity by human UDP-
RT   GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-
RT   GalNAc-T10).";
RL   J. Mol. Biol. 359:708-727(2006).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. Has activity toward Muc5Ac and EA2 peptide
CC       substrates.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:12417297}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q86SR1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86SR1-2; Sequence=VSP_011209;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q86SR1-3; Sequence=VSP_011212, VSP_011213;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q86SR1-4; Sequence=VSP_011207, VSP_011208, VSP_011214;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at high level in
CC       small intestine, and at intermediate levels in stomach, pancreas,
CC       ovary, thyroid gland and spleen. Weakly expressed in other
CC       tissues. {ECO:0000269|PubMed:12417297}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: According to experiments made in rat, this enzyme is
CC       unable to transfer GalNAc onto serine or threonine residue on the
CC       protein receptor, but instead requires the prior addition of a
CC       GalNAc on a peptide before adding additional GalNAc moieties,
CC       thereby acting as a glycopeptide transferase. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14676.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 10;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_492";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 10;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_493";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB078145; BAC56890.1; -; mRNA.
DR   EMBL; AJ505950; CAD44532.1; -; mRNA.
DR   EMBL; AK023782; BAB14676.1; ALT_INIT; mRNA.
DR   EMBL; AK127135; BAG54441.1; -; mRNA.
DR   EMBL; AL096739; CAB46378.1; -; mRNA.
DR   EMBL; AK074132; BAB84958.1; -; mRNA.
DR   EMBL; BC007224; AAH07224.2; -; mRNA.
DR   EMBL; BC072450; AAH72450.1; -; mRNA.
DR   CCDS; CCDS4325.1; -. [Q86SR1-1]
DR   PIR; T12552; T12552.
DR   RefSeq; NP_938080.1; NM_198321.3. [Q86SR1-1]
DR   UniGene; Hs.631797; -.
DR   PDB; 2D7I; X-ray; 2.50 A; A=40-603.
DR   PDB; 2D7R; X-ray; 2.80 A; A=40-603.
DR   PDBsum; 2D7I; -.
DR   PDBsum; 2D7R; -.
DR   ProteinModelPortal; Q86SR1; -.
DR   SMR; Q86SR1; -.
DR   BioGrid; 120723; 3.
DR   IntAct; Q86SR1; 1.
DR   MINT; MINT-2808648; -.
DR   STRING; 9606.ENSP00000297107; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q86SR1; -.
DR   PhosphoSitePlus; Q86SR1; -.
DR   SwissPalm; Q86SR1; -.
DR   BioMuta; GALNT10; -.
DR   DMDM; 51315962; -.
DR   MaxQB; Q86SR1; -.
DR   PaxDb; Q86SR1; -.
DR   PeptideAtlas; Q86SR1; -.
DR   PRIDE; Q86SR1; -.
DR   DNASU; 55568; -.
DR   Ensembl; ENST00000297107; ENSP00000297107; ENSG00000164574. [Q86SR1-1]
DR   Ensembl; ENST00000377661; ENSP00000366889; ENSG00000164574. [Q86SR1-2]
DR   Ensembl; ENST00000425427; ENSP00000415210; ENSG00000164574. [Q86SR1-3]
DR   GeneID; 55568; -.
DR   KEGG; hsa:55568; -.
DR   UCSC; uc003lvg.2; human. [Q86SR1-1]
DR   CTD; 55568; -.
DR   DisGeNET; 55568; -.
DR   GeneCards; GALNT10; -.
DR   HGNC; HGNC:19873; GALNT10.
DR   HPA; HPA007525; -.
DR   MIM; 608043; gene.
DR   neXtProt; NX_Q86SR1; -.
DR   OpenTargets; ENSG00000164574; -.
DR   PharmGKB; PA134870832; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q86SR1; -.
DR   KO; K00710; -.
DR   OMA; QKKTFFL; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q86SR1; -.
DR   TreeFam; TF313267; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT10; human.
DR   EvolutionaryTrace; Q86SR1; -.
DR   GenomeRNAi; 55568; -.
DR   PRO; PR:Q86SR1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164574; -.
DR   ExpressionAtlas; Q86SR1; baseline and differential.
DR   Genevisible; Q86SR1; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:GO_Central.
DR   GO; GO:0016266; P:O-glycan processing; IDA:GO_Central.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:GO_Central.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Glycosyltransferase; Golgi apparatus; Lectin; Manganese;
KW   Membrane; Metal-binding; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    603       Polypeptide N-
FT                                acetylgalactosaminyltransferase 10.
FT                                /FTId=PRO_0000059122.
FT   TOPO_DOM      1     11       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     12     31       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     32    603       Lumenal. {ECO:0000255}.
FT   DOMAIN      458    590       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      144    253       Catalytic subdomain A.
FT   REGION      311    373       Catalytic subdomain B.
FT   REGION      373    384       Flexible loop.
FT   METAL       237    237       Manganese.
FT   METAL       239    239       Manganese.
FT   METAL       370    370       Manganese.
FT   BINDING     154    154       Substrate.
FT   BINDING     156    156       Substrate.
FT   BINDING     185    185       Substrate.
FT   BINDING     214    214       Substrate.
FT   BINDING     238    238       Substrate.
FT   BINDING     342    342       Substrate.
FT   BINDING     373    373       Substrate.
FT   BINDING     378    378       Substrate.
FT   CARBOHYD    124    124       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16650853}.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16650853}.
FT   CARBOHYD    593    593       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16650853}.
FT   DISULFID    135    365       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16650853}.
FT   DISULFID    356    432       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16650853}.
FT   DISULFID    471    488       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16650853}.
FT   DISULFID    523    538       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16650853}.
FT   DISULFID    563    578       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16650853}.
FT   VAR_SEQ       1    329       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_011207.
FT   VAR_SEQ     190    251       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_011209.
FT   VAR_SEQ     330    352       WELGGYDPGLEIWGGEQYEISFK -> MLAWRDGELEAETS
FT                                SSLFLLAMQ (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_011208.
FT   VAR_SEQ     354    366       WMCGGRMEDIPCS -> SQLSRRPVLGTAS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:12693554}.
FT                                /FTId=VSP_011212.
FT   VAR_SEQ     367    603       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12693554}.
FT                                /FTId=VSP_011213.
FT   VAR_SEQ     389    389       N -> VRT (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_011214.
FT   CONFLICT    518    518       H -> Y (in Ref. 1; BAC56890 and 3;
FT                                BAB14676). {ECO:0000305}.
FT   HELIX        77     84       {ECO:0000244|PDB:2D7I}.
FT   HELIX        91     93       {ECO:0000244|PDB:2D7I}.
FT   TURN        100    103       {ECO:0000244|PDB:2D7I}.
FT   HELIX       106    109       {ECO:0000244|PDB:2D7I}.
FT   HELIX       115    119       {ECO:0000244|PDB:2D7I}.
FT   HELIX       133    136       {ECO:0000244|PDB:2D7I}.
FT   STRAND      140    143       {ECO:0000244|PDB:2D7I}.
FT   STRAND      147    155       {ECO:0000244|PDB:2D7I}.
FT   HELIX       158    171       {ECO:0000244|PDB:2D7I}.
FT   HELIX       174    176       {ECO:0000244|PDB:2D7I}.
FT   STRAND      177    184       {ECO:0000244|PDB:2D7I}.
FT   HELIX       190    192       {ECO:0000244|PDB:2D7I}.
FT   HELIX       194    200       {ECO:0000244|PDB:2D7I}.
FT   STRAND      206    210       {ECO:0000244|PDB:2D7I}.
FT   HELIX       217    227       {ECO:0000244|PDB:2D7I}.
FT   STRAND      230    235       {ECO:0000244|PDB:2D7I}.
FT   STRAND      238    242       {ECO:0000244|PDB:2D7I}.
FT   HELIX       248    256       {ECO:0000244|PDB:2D7I}.
FT   STRAND      260    269       {ECO:0000244|PDB:2D7I}.
FT   TURN        271    273       {ECO:0000244|PDB:2D7I}.
FT   STRAND      285    288       {ECO:0000244|PDB:2D7I}.
FT   STRAND      294    297       {ECO:0000244|PDB:2D7I}.
FT   TURN        301    303       {ECO:0000244|PDB:2D7I}.
FT   STRAND      319    325       {ECO:0000244|PDB:2D7I}.
FT   HELIX       326    331       {ECO:0000244|PDB:2D7I}.
FT   STRAND      341    344       {ECO:0000244|PDB:2D7I}.
FT   HELIX       345    355       {ECO:0000244|PDB:2D7I}.
FT   STRAND      359    370       {ECO:0000244|PDB:2D7I}.
FT   HELIX       386    397       {ECO:0000244|PDB:2D7I}.
FT   HELIX       399    401       {ECO:0000244|PDB:2D7I}.
FT   HELIX       402    406       {ECO:0000244|PDB:2D7I}.
FT   HELIX       410    412       {ECO:0000244|PDB:2D7I}.
FT   HELIX       421    430       {ECO:0000244|PDB:2D7I}.
FT   HELIX       435    441       {ECO:0000244|PDB:2D7I}.
FT   HELIX       446    449       {ECO:0000244|PDB:2D7I}.
FT   STRAND      458    465       {ECO:0000244|PDB:2D7I}.
FT   TURN        466    468       {ECO:0000244|PDB:2D7I}.
FT   TURN        478    480       {ECO:0000244|PDB:2D7I}.
FT   HELIX       495    497       {ECO:0000244|PDB:2D7I}.
FT   STRAND      503    505       {ECO:0000244|PDB:2D7I}.
FT   TURN        507    509       {ECO:0000244|PDB:2D7R}.
FT   STRAND      511    514       {ECO:0000244|PDB:2D7I}.
FT   STRAND      521    525       {ECO:0000244|PDB:2D7R}.
FT   STRAND      528    532       {ECO:0000244|PDB:2D7I}.
FT   STRAND      534    537       {ECO:0000244|PDB:2D7R}.
FT   STRAND      540    543       {ECO:0000244|PDB:2D7I}.
FT   STRAND      548    550       {ECO:0000244|PDB:2D7R}.
FT   TURN        551    553       {ECO:0000244|PDB:2D7R}.
FT   STRAND      554    556       {ECO:0000244|PDB:2D7R}.
FT   TURN        558    560       {ECO:0000244|PDB:2D7I}.
FT   STRAND      563    566       {ECO:0000244|PDB:2D7I}.
FT   TURN        568    570       {ECO:0000244|PDB:2D7I}.
FT   STRAND      573    576       {ECO:0000244|PDB:2D7I}.
FT   STRAND      587    591       {ECO:0000244|PDB:2D7I}.
FT   HELIX       594    597       {ECO:0000244|PDB:2D7I}.
FT   TURN        598    601       {ECO:0000244|PDB:2D7I}.
SQ   SEQUENCE   603 AA;  68992 MW;  EE176F6139B92573 CRC64;
     MRRKEKRLLQ AVALVLAALV LLPNVGLWAL YRERQPDGTP GGSGAAVAPA AGQGSHSRQK
     KTFFLGDGQK LKDWHDKEAI RRDAQRVGNG EQGRPYPMTD AERVDQAYRE NGFNIYVSDK
     ISLNRSLPDI RHPNCNSKRY LETLPNTSII IPFHNEGWSS LLRTVHSVLN RSPPELVAEI
     VLVDDFSDRE HLKKPLEDYM ALFPSVRILR TKKREGLIRT RMLGASVATG DVITFLDSHC
     EANVNWLPPL LDRIARNRKT IVCPMIDVID HDDFRYETQA GDAMRGAFDW EMYYKRIPIP
     PELQKADPSD PFESPVMAGG LFAVDRKWFW ELGGYDPGLE IWGGEQYEIS FKVWMCGGRM
     EDIPCSRVGH IYRKYVPYKV PAGVSLARNL KRVAEVWMDE YAEYIYQRRP EYRHLSAGDV
     AVQKKLRSSL NCKSFKWFMT KIAWDLPKFY PPVEPPAAAW GEIRNVGTGL CADTKHGALG
     SPLRLEGCVR GRGEAAWNNM QVFTFTWRED IRPGDPQHTK KFCFDAISHT SPVTLYDCHS
     MKGNQLWKYR KDKTLYHPVS GSCMDCSESD HRIFMNTCNP SSLTQQWLFE HTNSTVLEKF
     NRN
//
